This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Encephalitis  • Epilepsy  • Neuropathology  • Neurology, Other  • Rheumatology, Other  • Diagnosis  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

David Pleasure, MD

Arch Neurol. 2008;65(5):589-592.

Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.

Author Affiliation: Departments of Neurology and Pediatrics, University of California, Davis, School of Medicine, Sacramento.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(5):572-573.
FULL TEXT